Anterix Inc. — Director's Dealing 2023

Mar 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2023-03-13

Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-13	Common Stock	M	20000	$20.00	Acquired	51947	Direct
2023-03-13	Common Stock	M	20000	$22.75	Acquired	71947	Direct
2023-03-13	Common Stock	S	5000	$30.2946	Disposed	66947	Direct
2023-03-13	Common Stock	S	40000	$30.0125	Disposed	26947	Direct
2022-10-12	Common Stock	G	1000	$0.00	Disposed	25947	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-13	Stock Option (Right to Buy)	$20.00	M	20000	Disposed	2024-05-14	Common Stock (20000)	Direct
2023-03-13	Stock Option (Right to Buy)	$22.75	M	20000	Disposed	2027-05-22	Common Stock (20000)	Direct

Footnotes

F1: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.79 to $30.56. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.77 to $30.28. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: These transactions represent a charitable contribution by the Reporting Person.

F4: The option shares are fully vested.